You can buy or sell Flex Pharma and other stocks, options, ETFs, and crypto commission-free!
Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. Read More The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 1
Flex Pharma Reports First Quarter 2019 Financial Results
BOSTON--(BUSINESS WIRE)-- Flex Pharma, Inc. (FLKS), today announced its financial results for the three months ended March 31, 2019. On January 3, 2019, Flex Pharma (the "Company") and Salarius Pharmaceuticals, LLC ("Salarius") entered into an Agreement and Plan of Merger (the "Merger Agreement") pursuant to which, among other things, Falcon Acquisition Sub, LLC, a wholly owned subsidiary of the Company, will merge with and into Salarius, with Salarius continuing as a wholly owned subsidiary of the Compan...
Yahoo FinanceApr 26
FLKS ALERT: Monteverde & Associates PC Encourages Flex Pharma, Inc. Shareholders to Contact the Firm
Expected Jul 31, Pre-Market